175 related articles for article (PubMed ID: 22148038)
1. Syringocystadenoma papilliferum of the back combined with a tubular apocrine adenoma.
Lee HJ; Cho E; Kim MH; Cho SH; Lee JD
Ann Dermatol; 2011 Oct; 23(Suppl 2):S151-4. PubMed ID: 22148038
[TBL] [Abstract][Full Text] [Related]
2. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
[TBL] [Abstract][Full Text] [Related]
3. A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.
Kim MS; Lee JH; Lee WM; Son SJ
Ann Dermatol; 2010 Aug; 22(3):319-22. PubMed ID: 20711270
[TBL] [Abstract][Full Text] [Related]
4. Syringocystadenoma Papilliferum in Co-existence with Tubular Apocrine Adenoma on the Calf.
Yoon JH; Ahn HH; Kye YC; Seo SH
Ann Dermatol; 2011 Oct; 23(Suppl 2):S175-8. PubMed ID: 22148043
[TBL] [Abstract][Full Text] [Related]
5. Complex sweat gland hamartoma: A case report.
Skopec Z; Berrebi KG; Stone M; Liu V
J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
[TBL] [Abstract][Full Text] [Related]
6. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
Ansai SI; Anan T; Fukumoto T; Saeki H
Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
[TBL] [Abstract][Full Text] [Related]
7. Trilogy Revisited: A Case Report of Co-Existing Nevus Sebaceous with Syringocystadenoma Papilliferum and Tubular Apocrine Adenoma.
Bardia A; Chatterjee D; Vinay K
Indian Dermatol Online J; 2021; 12(4):577-579. PubMed ID: 34430463
[TBL] [Abstract][Full Text] [Related]
8. Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.
Xu D; Bi T; Lan H; Yu W; Wang W; Cao F; Jin K
Onco Targets Ther; 2013; 6():233-6. PubMed ID: 23569386
[TBL] [Abstract][Full Text] [Related]
9. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
[TBL] [Abstract][Full Text] [Related]
10. Is tubular apocrine adenoma a distinct clinical entity?
Ishiko A; Shimizu H; Inamoto N; Nakmura K
Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated Squamous Cell Carcinoma Arising in Syringocystadenoma Papilliferum.
Singh MP; Choudhary SV; Chaurasia JK
Indian Dermatol Online J; 2019; 10(2):168-170. PubMed ID: 30984594
[TBL] [Abstract][Full Text] [Related]
12. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
Ito K; Ansai SI; Saeki H
J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
[TBL] [Abstract][Full Text] [Related]
13. Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologists.
Kazakov DV; Bisceglia M; Calonje E; Hantschke M; Kutzner H; Mentzel T; Michal M; Mukensnabl P; Spagnolo DV; Rütten A; Rose C; Urso C; Vazmitel M; Zelger B
Am J Dermatopathol; 2007 Jun; 29(3):256-63. PubMed ID: 17519623
[TBL] [Abstract][Full Text] [Related]
14. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
Aktepe F; Demir Y; Dilek FH
Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
[TBL] [Abstract][Full Text] [Related]
15. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
Hsu PJ; Liu CH; Huang CJ
J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
[TBL] [Abstract][Full Text] [Related]
16. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
[TBL] [Abstract][Full Text] [Related]
17. Unusual Complex Apocrine Tumor Consisting of Syringocystadenoma Papilliferum and Apocrine Hidrocystoma within a Single Lesion: A Case Report.
Kim JH; Uh JA; Lee JH; Kim HY; Lee SK; Kim MS; Lee UH
Ann Dermatol; 2023 Feb; 35(1):66-70. PubMed ID: 36750461
[TBL] [Abstract][Full Text] [Related]
18. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
[TBL] [Abstract][Full Text] [Related]
19. Syringocystadenoma papilliferum: report of 8 cases.
Rammeh-Rommani S; Fezaa B; Chelbi E; Kammoun MR; Ben Jilani SB; Zermani R
Pathologica; 2006 Jun; 98(3):178-80. PubMed ID: 17036946
[TBL] [Abstract][Full Text] [Related]
20. A case of tubular apocrine adenoma with syringocystadenoma papilliferum.
Ansai S; Watanabe S; Aso K
J Cutan Pathol; 1989 Aug; 16(4):230-6. PubMed ID: 2551940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
